Obama promotes influx of foreign investment in US

By: 11 years ago

This May 12, 2014, file photo shows President Barack Obama speaking during a press availability with Uruguay’s President Jose Mujica in the Oval Office of the White House in Washington. AP

WASHINGTON — President Barack Obama held a little-noticed meeting in March with executives of a Belgian aerospace company while in Brussels to meet European leaders. It was barely a footnote in a trip dominated by tensions with Russia over Ukraine.

But the meeting was the result of a lengthy courtship by the Obama administration and the state of Oklahoma to attract ASCO Industries to build a new $125 million production facility in the US

The effort was part of an initiative called SelectUSA that Obama started in 2011 and expanded last year.

Obama this week is drawing new attention to the effort, convening business leaders Tuesday at the White House to advertise success stories in the face of public anxieties over jobs and the economy.

Among the recent deals is a decision by a subsidiary of Germany-based Lufthansa to build aviation maintenance and repair center in Puerto Rico. White House officials say it was sealed through direct phone calls with Lufthansa executives from Commerce Secretary Penny Pritzker and Vice President Joe Biden.

Yet as Obama promotes the influx of foreign investment to the US, his administration and key members of Congress are also worrying over dozens of US companies heading in the other direction. These businesses are merging with or acquiring overseas firms to change their address and gain tax advantages that can cost the federal government billions in tax revenues.

The most prominent example is Pfizer Inc.’s recent takeover bid of British drugmaker AstraZeneca, a deal that if consummated would be the largest-ever foreign takeover of a British company. The potential acquisition would allow Pfizer to incorporate in Britain and thus limit its exposure to higher US corporate tax rates. On Monday, AstraZeneca turned down Pfizer’s latest offer of $119 billion, making the likelihood of a deal increasingly unlikely.

Pfizer’s approach — called a corporate inversion — is the latest in a growing trend that could accelerate as corporate lawyers advice clients to get ahead of efforts in Washington to overhaul the tax system and close corporate loopholes. Companies that have created foreign shell corporations in recent years include familiar names like Tyco International and Ingersoll-Rand.

Though there is little chance of action this year, Republicans and Democrats generally agree that federal corporate tax rates, now at 35 percent, should be lowered while eliminating credits, exemptions and other tax advantages.

Still, the Obama administration’s 2015 budget contained a specific proposal aimed at curtailing inversions and White House officials say such a fix would not necessarily have to be part of a broader overhaul.

Under current law, a US company that merges with a foreign entity can’t benefit from a lower foreign tax rate unless the shareholders of the foreign company own at least 20 percent of the new merged business. Obama has proposed raising that threshold to 50 percent, with the goal of making them less attractive.

But Republicans and some corporate advisers say inversion transactions will continue as long as US corporate tax rates remain the highest among industrialized countries and as long as the United States requires US companies to pay taxes on any foreign cash that are brought back to the United States.

“That creates a very strong incentive for major US companies to keep their cash earned overseas overseas” said Gordon Caplan, a partner in the New York law firm of Willkie Farr & Gallagher who specializes in mergers and acquisitions.

The attention comes as foreign direct investments last year rebounded, from $166 billion in 2012 to $193 billion in 2013, still far short of the $310 billion in 2008. The figure, though, is nearly on track to meet Obama’s goal of attracting $1 trillion in new foreign investments over the next five years.

A survey last fall by the Boston Consulting Group, a global management consulting firm, found that 54 percent of executives of large US-based manufacturing firms said they planned on or were considering moving production facilities back to the U.S. from China. That was up from the 37 percent a year earlier.

And the latest survey of confidence in foreign direct investment by A.T. Kearney, another global management consulting firm, found that the United States had regained the top spot as an investment destination for the first time since 2001.